Almost 80 European deep tech university spinouts reached $1B valuations or $100M in revenue in 2025

Europe's universities and research institutions are proving to be a goldmine for deep tech innovation. Recent data from Dealroom’s European Spinout Report 2025 reveals that an impressive 76 deep tech and life sciences startups have either reached valuations of $1 billion or generated revenues of $100 million, reflecting a robust startup ecosystem valued at approximately $398 billion. Among these standout companies are unicorns such as Iceye, IQM, Isar Aerospace, Synthesia, and Tekever, which are setting a precedent and attracting increased venture capital interest in university spinouts. Notably, two new funds have emerged this month, poised to enhance financial support for the talent cultivated in Europe's tech universities, with Cambridge, Oxford, and ETH Zurich leading the pipeline. Denmark's PSV Hafnium has recently closed its first fund at an oversubscribed €60 million (around $71 million), focusing on Nordic deep tech ventures. Meanwhile, U2V (University2Ventures), with offices in Berlin and London, aims to raise a similar amount for its inaugural fund, having already completed its first closing. These firms join an expanding network of European venture capitalists prioritizing university spinouts in their investment strategies. The trend was initially kickstarted by entities like Cambridge Innovation Capital and Oxford Science Enterprises, which have matured into established players. Today, the landscape is more diverse, incorporating independent firms that recognize the potential of spinouts as lucrative investment opportunities. For instance, Oxford Ionics, which was acquired by the U.S.-based IonQ, is among the six spinouts from Switzerland, the U.K., and Germany that secured exits exceeding $1 billion in 2025. Funding for these university spinouts is also on the rise, with projections indicating they are set to raise nearly $9.1 billion in 2025, marking one of the highest amounts recorded. This surge contrasts sharply with the overall venture capital funding landscape in Europe, which has decreased by nearly 50% from its peak in 2021. Noteworthy funding rounds in 2025 highlight the growing interest in diverse sectors, including nuclear energy with companies like Proxima Fusion, and dual-use drones represented by Quantum Systems, now valued over $3 billion. Many of these startups leverage cutting-edge research from specialized laboratories, contributing to a wide array of European locations capable of producing successful spinouts. Building partnerships with research hubs beyond the traditional centers like Oxbridge is becoming a strategic focus for newcomers seeking to carve out a niche and discover promising deals. PSV Hafnium's partners emphasized the untapped potential of the Nordic region’s research institutions in a recent statement, as they look to invest in startups across these countries. For instance, SisuSemi, a Finnish startup utilizing a decade of research from the University of Turku, is developing innovative surface cleaning technologies for the semiconductor industry, benefiting from the increased availability of funding. While the influx of grants, commercialization support, and favorable deal terms foster an encouraging environment for Europe's spinouts, a significant hurdle remains: the availability of growth capital. The report highlights that this issue is not isolated to spinouts but affects the entire European startup ecosystem. Currently, nearly 50% of late-stage funding for deep tech and life sciences spinouts in Europe is sourced from outside the continent, predominantly from the U.S. Although this figure has decreased over time, Europe must address this trend to fully leverage its investments in talent and research, underscoring a broader challenge that needs resolution.